SCHEMBL5731479

SCHEMBL5731479

CC(C)(C)OC(=O)N[C@@H](Cc1ccc(-c2ncnc3c2ncn3Cc2ccccc2)cc1)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 2/20 0.53
FGFR4 P22455 2/20 0.53
ACE P12821 2/20 0.52
PTPN1 P18031 2/20 0.47
CTSS P25774 3/20 0.46
CTSK P43235 2/20 0.46
ITGA4 P13612 2/20 0.46
ITGB7 P26010 2/20 0.46
ITGB3 P05106 1/20 0.45
ITGA2B P08514 1/20 0.45
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
PPARA Q07869 2/20 0.43
PPARG P37231 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
PDE4D Q08499 1/20 0.43
MAPK1 P28482 1/20 0.43
FGFR2 P21802 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5731477 1.00 FGFR1 (0.53) FGFR1FGFR4ACEPTPN1CTSS
SCHEMBL5731483 1.00 FGFR1 (0.53) FGFR1FGFR4ACEPTPN1CTSS
SCHEMBL5732885 0.93 FGFR1 (0.51) FGFR1FGFR4ACECTSSCTSK
SCHEMBL5925935 0.93 FGFR1 (0.51) FGFR1FGFR4ACECTSSCTSK
SCHEMBL5925939 0.93 FGFR1 (0.51) FGFR1FGFR4ACECTSSCTSK
SCHEMBL5731429 0.87 ACE (0.51) ACEPTPN1CTSSCTSKCTSL
SCHEMBL5731489 0.87 ACE (0.51) ACEPTPN1CTSSCTSKCTSL
SCHEMBL5731430 0.87 ACE (0.51) ACEPTPN1CTSSCTSKCTSL
SCHEMBL5925937 0.85 FGFR1 (0.48) FGFR1FGFR4PDE4APDE4BPDE4C
Dimethylformamide SCHEMBL5732103 0.81 ACE (0.46) FGFR1FGFR4ACEPTPN1PPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) 2006-06-15 US disclosed
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CESKE REPUBLIKY (CZ) 2006-06-15 US disclosed
EP-1615926-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) 2006-01-18 EP disclosed
EP-1615926-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF Ustav Organicke Chemie A Biochemie Akademie Ved Ceske Republiky (CZ) 2006-01-18 EP disclosed
CN-1720246-A (Purin-6-yl) amino acid and production method thereof USTAV ORGANICKE CHEMIE A BIOCH (CZ) 2006-01-11 CN disclosed
WO-2004094426-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF USTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKÉ REPUBLIKY (CZ) 2004-11-04 WO disclosed
WO-2004094426-A1 (PURIN-6-YL) AMINO ACID AND PRODUCTION METHOD THEREOF USTAV ORGANICKÉ CHEMIE A BIOCHEMIE AKADEMIE VED CESKÉ REPUBLIKY (CZ) 2004-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060128956-A1 (Purin-6-yl) amino acid and production method thereof PRPF3, PURB, PRPF31 FGFR1 4754/4885FGFR4 3891/4885ACE 2964/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.